The Algeta Story
Originally only a small team, Algeta remains true to its heritage while steadily expanding into a global oncology company.
Alpha-pharmaceuticals represent a new class of cancer therapy that utilizes the properties of alpha-particle emitters to destroy cancer cells.
Algeta’s leadership position in this area has been developed through its expertise in radiochemistry, nuclear medicine, and medical oncology.
"The same state-of-the-art facilities that Algeta uses to produce high-quality radium-223 also generate thorium-227 as part of the manufacturing process"
Corporate strategy
Algeta’s strategy is to build a commercial operation as well as expand its portfolio of oncology product candidates.
Code of Ethics
Algeta have a firm code of ethics in place to ensure we remain a business of fairness and integrity.